Trial Profile

A multiple dose-escalating phase 1 trial of STM-01 in pediatric patients with dilated cardiomyopathy

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 28 Nov 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

24 Nov 2025 New trial record
28 Oct 2025 According to a Secretome Therapeutics press release, if the phase 1 trial in adults with DCM, is found to be safe and well-tolerated, then company will proceed with phase 1 multiple ascending dose study in pediatric DCM (pDCM).
28 Oct 2025 According to a Secretome Therapeutics media release, the adult and pediatric trials are funded by a grant from The Marcus Foundation and will take place at the Marcus Center for Cellular Therapy at Children's Arthur M. Blank Hospital, part of Children's Healthcare of Atlanta.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com